APA (7th ed.) Citation

Kievit, W., Jacobs, C., Teerenstra, S., Kievit, W., Teerenstra, S., Vries, M. d., . . . Becker-Commissaris, A. (2025). Beneficial value of [18F]FDG PET/CT in the follow-up of patients with stage III non-small cell lung cancer (NVALT31-PET study): Study protocol of a multicentre randomised controlled trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Kievit, Wietske, et al. Beneficial Value of [18F]FDG PET/CT in the Follow-up of Patients with Stage III Non-small Cell Lung Cancer (NVALT31-PET Study): Study Protocol of a Multicentre Randomised Controlled Trial. BMJ Publishing Group, 2025.

MLA (9th ed.) Citation

Kievit, Wietske, et al. Beneficial Value of [18F]FDG PET/CT in the Follow-up of Patients with Stage III Non-small Cell Lung Cancer (NVALT31-PET Study): Study Protocol of a Multicentre Randomised Controlled Trial. BMJ Publishing Group, 2025.